Home Cart 0 Sign in  
X

[ CAS No. 21575-91-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 21575-91-7
Chemical Structure| 21575-91-7
Chemical Structure| 21575-91-7
Structure of 21575-91-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 21575-91-7 ]

Related Doc. of [ 21575-91-7 ]

Alternatived Products of [ 21575-91-7 ]

Product Details of [ 21575-91-7 ]

CAS No. :21575-91-7 MDL No. :MFCD03424812
Formula : C11H11BrO3 Boiling Point : -
Linear Structure Formula :- InChI Key :JSVMCOQPWKQNGU-UHFFFAOYSA-N
M.W : 271.11 Pubchem ID :179368
Synonyms :

Calculated chemistry of [ 21575-91-7 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.27
Num. rotatable bonds : 5
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 60.04
TPSA : 43.37 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.14 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.55
Log Po/w (XLOGP3) : 2.56
Log Po/w (WLOGP) : 2.59
Log Po/w (MLOGP) : 2.3
Log Po/w (SILICOS-IT) : 3.0
Consensus Log Po/w : 2.6

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.1
Solubility : 0.216 mg/ml ; 0.000795 mol/l
Class : Soluble
Log S (Ali) : -3.12
Solubility : 0.206 mg/ml ; 0.000761 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.08
Solubility : 0.0223 mg/ml ; 0.0000824 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 1.86

Safety of [ 21575-91-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 21575-91-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 21575-91-7 ]
  • Downstream synthetic route of [ 21575-91-7 ]

[ 21575-91-7 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 24398-88-7 ]
  • [ 141-78-6 ]
  • [ 21575-91-7 ]
YieldReaction ConditionsOperation in experiment
76.9%
Stage #1: With lithium hexamethyldisilazane In tetrahydrofuran at -78℃; for 0.25 h; Inert atmosphere
Stage #2: at -78℃; for 2 h; Inert atmosphere
[00457] To a stirred solution of 1.3 M LHMDS (25 mL, 32.7 mmol) in THF (10 mL) was added EtOAc (1.9 g, 21.8 mmol) at -78 °C under inert atmosphere. After being stirred for 15 min, ethyl- 3-bromo benzoate (5 g, 21.8 mmol) was added and stirring was continued for 2 h; progress of the reaction was monitored by TLC. The reaction was quenched with aq. NH4C1 (10 mL) and extracted with EtOAc (3 x 20 mL). The combined organic extracts were dried over anhydrous Na2SO4 and concentrated under reduced pressure to obtain the crude product. The crude material was purified by silica gel column chromatography eluting with 4percent EtOAc/Hexane to afford compound G (4.5 g, 76.9percent) as a mixture with its enolic form as a brown oil. 1H NMR (500 MHz, CDCls): δ 8.07 (s, 1H), 7.86 (d, J= 7.5 Hz, 1H), 7.73-7.69 (m, 1H), 7.37 (t, J= 7.0 Hz, 1H), 4.28-4.26 (m, 2H), 3.92 (s, 2H), 1.24 (t, J= 6.2 Hz, 3H). MS (ESI): m/z 298.8 [M-l].
Reference: [1] Patent: WO2015/191630, 2015, A1, . Location in patent: Paragraph 00457
[2] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 13, p. 2991 - 3013
  • 2
  • [ 95-92-1 ]
  • [ 21575-91-7 ]
YieldReaction ConditionsOperation in experiment
93%
Stage #1: With sodium hydride In DMF (N,N-dimethyl-formamide) at 0 - 20℃; for 0.583333 h;
Stage #2: at 0 - 20℃; for 16 h;
Stage #3: With hydrogenchloride; water In DMF (N,N-dimethyl-formamide)
To a suspension of sodium hydride (0.361 g, 9 mmol) in DMF (9.4 ML) was added 3- bromoacetophenone (0.99 ML, 9.53 mmol) at 0°C and stirred at room temperature for 35 minutes. The reaction mixture was then cooled to 0°C and diethyloxalate (1.32 ML, 9.7 mmol) was added followed by stirring at room temperature for 16 hours. The reaction was then poured into ice-water and acidified with IN HC1. The solid precipitate formed was filtered, washed with cold water and dried under vacuum to give the titled product (2.1 g, 93 percent) as a yellow solid.
Reference: [1] Patent: WO2004/92140, 2004, A1, . Location in patent: Page 56-57
  • 3
  • [ 1711-09-7 ]
  • [ 6148-64-7 ]
  • [ 21575-91-7 ]
YieldReaction ConditionsOperation in experiment
99% With magnesium chloride; triethylamine In acetonitrile Example 2 Part A
3-(3-Bromophenyl)-3-oxopropanoic Acid Ethyl Ester
To potassium ethyl malonate (3.25 g, 19.13 mmol) in acetonitrile (50 mL) was sequentially added triethyl amine (4.1 mL, 29.16 mmol) and magnesium chloride (2.16 g, 22.78 mmol) at room temperature.
After stirring the reaction mixture at room temperature for 2 hours, 3-bromobenzoyl chloride (2.0 g, 9.11 mmol) was added and the mixture was heated at 60° C. for 18 hours, concentrated under reduced pressure and partitioned between ethyl acetate (100 mL) and 1N HCl (25 mL).
The ethyl acetate layer was dried over sodium sulfate and concentrated under reduced pressure to yield the title compound (2.45 g, 99percent).
1H NMR (CDCl3): δ 8.1 (s, 1H), 7.85 (d, 1H), 7.7 (d, 1H), 7.35 (t, 1H), 4.3 (m, 2H), 3.4 (s, 1H), 1.3 (m, 3H).
Reference: [1] Patent: US2002/40022, 2002, A1,
  • 4
  • [ 2142-63-4 ]
  • [ 105-58-8 ]
  • [ 21575-91-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 6, p. 1910 - 1915
[2] Farmaco, Edizione Scientifica, 1985, vol. 40, # 4, p. 272 - 284
[3] Organic Letters, 2017, vol. 19, # 23, p. 6344 - 6347
[4] Organic and Biomolecular Chemistry, 2018, vol. 16, # 25, p. 4683 - 4687
  • 5
  • [ 623-73-4 ]
  • [ 3132-99-8 ]
  • [ 21575-91-7 ]
Reference: [1] Tetrahedron, 2005, vol. 61, # 4, p. 875 - 878
  • 6
  • [ 51699-41-3 ]
  • [ 21575-91-7 ]
Reference: [1] Chemistry - An Asian Journal, 2011, vol. 6, # 8, p. 2073 - 2079
  • 7
  • [ 811467-20-6 ]
  • [ 21575-91-7 ]
Reference: [1] Tetrahedron Letters, 2006, vol. 47, # 50, p. 8859 - 8861
[2] Tetrahedron Letters, 2007, vol. 48, # 7, p. 1147 - 1149
  • 8
  • [ 2142-63-4 ]
  • [ 105-58-8 ]
  • [ 21575-91-7 ]
Reference: [1] Chemistry - An Asian Journal, 2016, vol. 11, # 3, p. 395 - 400
  • 9
  • [ 585-76-2 ]
  • [ 6148-64-7 ]
  • [ 21575-91-7 ]
Reference: [1] RSC Advances, 2018, vol. 8, # 27, p. 15009 - 15020
  • 10
  • [ 3132-99-8 ]
  • [ 21575-91-7 ]
Reference: [1] Chemistry - An Asian Journal, 2011, vol. 6, # 8, p. 2073 - 2079
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 21575-91-7 ]

Aryls

Chemical Structure| 26510-95-2

[ 26510-95-2 ]

Ethyl 3-(4-bromophenyl)-3-oxopropanoate

Similarity: 0.98

Chemical Structure| 1208318-08-4

[ 1208318-08-4 ]

Ethyl 7-(4-bromophenyl)-4,7-dioxoheptanoate

Similarity: 0.96

Chemical Structure| 30913-87-2

[ 30913-87-2 ]

Ethyl 4-(4-bromophenyl)-4-oxobutanoate

Similarity: 0.96

Chemical Structure| 30913-86-1

[ 30913-86-1 ]

Methyl 4-(4-bromophenyl)-4-oxobutanoate

Similarity: 0.93

Chemical Structure| 294881-08-6

[ 294881-08-6 ]

Methyl (2-bromobenzoyl)acetate

Similarity: 0.86

Bromides

Chemical Structure| 26510-95-2

[ 26510-95-2 ]

Ethyl 3-(4-bromophenyl)-3-oxopropanoate

Similarity: 0.98

Chemical Structure| 1208318-08-4

[ 1208318-08-4 ]

Ethyl 7-(4-bromophenyl)-4,7-dioxoheptanoate

Similarity: 0.96

Chemical Structure| 30913-87-2

[ 30913-87-2 ]

Ethyl 4-(4-bromophenyl)-4-oxobutanoate

Similarity: 0.96

Chemical Structure| 30913-86-1

[ 30913-86-1 ]

Methyl 4-(4-bromophenyl)-4-oxobutanoate

Similarity: 0.93

Chemical Structure| 294881-08-6

[ 294881-08-6 ]

Methyl (2-bromobenzoyl)acetate

Similarity: 0.86

Esters

Chemical Structure| 26510-95-2

[ 26510-95-2 ]

Ethyl 3-(4-bromophenyl)-3-oxopropanoate

Similarity: 0.98

Chemical Structure| 1208318-08-4

[ 1208318-08-4 ]

Ethyl 7-(4-bromophenyl)-4,7-dioxoheptanoate

Similarity: 0.96

Chemical Structure| 30913-87-2

[ 30913-87-2 ]

Ethyl 4-(4-bromophenyl)-4-oxobutanoate

Similarity: 0.96

Chemical Structure| 30913-86-1

[ 30913-86-1 ]

Methyl 4-(4-bromophenyl)-4-oxobutanoate

Similarity: 0.93

Chemical Structure| 294881-08-6

[ 294881-08-6 ]

Methyl (2-bromobenzoyl)acetate

Similarity: 0.86

Ketones

Chemical Structure| 26510-95-2

[ 26510-95-2 ]

Ethyl 3-(4-bromophenyl)-3-oxopropanoate

Similarity: 0.98

Chemical Structure| 1208318-08-4

[ 1208318-08-4 ]

Ethyl 7-(4-bromophenyl)-4,7-dioxoheptanoate

Similarity: 0.96

Chemical Structure| 30913-87-2

[ 30913-87-2 ]

Ethyl 4-(4-bromophenyl)-4-oxobutanoate

Similarity: 0.96

Chemical Structure| 30913-86-1

[ 30913-86-1 ]

Methyl 4-(4-bromophenyl)-4-oxobutanoate

Similarity: 0.93

Chemical Structure| 294881-08-6

[ 294881-08-6 ]

Methyl (2-bromobenzoyl)acetate

Similarity: 0.86